Insider sale
IMPACT BIOMEDICAL INC.
$23.06M
31.94M shares
What this filing means
DSS, INC. plans to sell 31.94M shares of IMPACT BIOMEDICAL INC. valued at approximately $23.06M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/29/2026ACC: 0001493152-26-019682
31.94M
Shares to sell
$23.06M
Approx. market value
31.94M
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
31,939,778 were issued to DSS by the issuing company in full and final satisfaction of the Second Amended Promissory Note.
Series rendered
6/21/2025
31.94MTotal acquired31.94M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/21/2025 | 31,939,778 were issued to DSS by the issuing company in full and final satisfaction of the Second Amended Promissory Note. Series rendered | 31.94M | — |
| Total | 31.94M | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
31.94M
Market value
$23.06M
4/22/2026
Total
Units
31.94M
Value
$23.06M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/22/2026 | 31.94M | $23.06M | NYSE | Planned |
| Total | 31.94M | $23.06M | ||